Patent Assignment
Reel/Frame 043596/0259
Notice of Grant of Security Interest in Patents
Recorded: 2017-08-18
Pages: 18
Assignor
MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY
Executed: 2017-08-17
Assignee
DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
60 WALL STREET, NEW YORK, NEW YORK, 10005
Covered Properties
(35)
Biocompatible Phase Invertable Proteinaceous Compositions and Methods for Making and Using the Same
Thrombin Compositions
Thrombin Compositions
Biocompatible Phase Invertable Proteinaceous Compositions and Methods for Making and Using the Same
Method for Activating Prethrombin-1
Stabilized Thrombin Compositions
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Dry Powder Fibrin Sealant
Biocompatible Phase Invertable Proteinaceous Compositions and Methods for Making and Using the Same
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Hemostatic Microspheres
Thrombin Activator Compositions and Methods of Making and Using the Same
Medical Devices for Delivering Fluids During Surgery and Methods for Their Use
Recombinant Fibrinogen
Application:
13/002,797 →
Publication:
US 2011/0177524
Powder Delivery Device
Biodegradable Extravascular Stent
Application:
13/147,969 →
Publication:
US 2012/0016465
Treatment of Tissue Adhesion
Dry Powder Fibrin Sealant
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Dry Powder Fibrin Sealant
Powder Delivery Device
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Formulations for Wound Therapy
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Powder Formulation Comprising Thrombin and Fibrinogen
Application:
14/773,212 →
Publication:
US 2016/0015792
Biocompatible Phase Invertable Proteinaceous Compositions And Methods For Making And Using The Same
Fibrinogen Preparations Enriched in Fibrinogen With An Extended Alpha Chain
Biocompatible Phase Invertible Proteinaceous Compositions and Methods for Making and Using the Same
Recombinant Fibrinogen
Biodegradable Extravascular Stent
Medical Devices for Delivering Fluids During Surgery and Methods for Their Use
Application:
15/422,114 →
Publication:
US 2017/0143321
Medical Instrument
Patent:
628,692 →
Application:
29/339,045 →
Medical Powder Delivery Instrument
Patent:
683,851 →
Application:
29/394,931 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 22, 2015
From: ZYMOGENETICS, LLC
To: THE MEDICINES COMPANY
Reel/Frame 035988/0724 →
Assignment of Assignor's Interest
Dec 1, 2016
From: PROFIBRIX BV
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 040482/0609 →
Assignment of Assignor's Interest
Jan 30, 2017
From: THE MEDICINES COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 041119/0930 →
Assignment of Assignor's Interest
Jan 30, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 041119/0963 →
Assignment of Assignor's Interest
Aug 4, 2017
From: PROFIBRIX BV
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043197/0243 →
Nunc Pro Tunc Assignment
Sep 28, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043723/0478 →
Nunc Pro Tunc Assignment
Sep 28, 2017
From: THE MEDICINES COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 043723/0188 →
Corrective Assignment to Correct the Signatory Pages on Supporting Document Previously Recorded at Reel: 043723 Frame: 0478. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment.
Oct 3, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 044570/0091 →
Nunc Pro Tunc Assignment
Oct 3, 2017
From: TENAXIS MEDICAL, INC.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043767/0923 →
Nunc Pro Tunc Assignment
Oct 6, 2017
From: PROFIBRIX B.V.
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043806/0028 →
Assignment of Assignor's Interest
May 9, 2018
From: MALLINCKRODT PHARMA IP TRADING DAC
To: BAXTER INTERNATIONAL, INC.
Reel/Frame 045754/0904 →
Assignment of Assignor's Interest
May 18, 2018
From: MATRIX MEDICAL LLC
To: TENAXIS MEDICAL, INC.
Reel/Frame 045840/0864 →
Assignment of Assignor's Interest
May 24, 2018
From: JIANG, SHAN; SENDEROFF, RICHARD I.; MEYER, JEFFREY D.
To: ZYMOGENETICS, INC.
Reel/Frame 045896/0374 →
Assignment of Assignor's Interest
Jun 6, 2018
From: MATRIX MEDICAL, LLC
To: TENAXIS MEDICAL, INC.
Reel/Frame 046004/0072 →
Assignment of Assignor's Interest
Jun 12, 2018
From: MALLINCKRODT PHARMA IP TRADING DAC
To: BAXTER INTERNATIONAL, INC.
Reel/Frame 046051/0900 →
Assignment of Assignor's Interest
Jun 13, 2018
From: MATRIX MEDICAL, LLC
To: TENAXIS MEDICAL, INC.
Reel/Frame 046066/0483 →
Assignment of Assignor's Interest
Jun 13, 2018
From: MALLINCKRODT PHARMA IP TRADING DAC
To: BAXTER INTERNATIONAL, INC.
Reel/Frame 046067/0652 →
Assignment of Assignor's Interest
Jun 14, 2018
From: MATRIX MEDICAL, LLC
To: TENAXIS MEDICAL, INC.
Reel/Frame 046089/0659 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →